MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma

被引：12
|
作者：
Olarte, Irma [1 ]
Martinez, Adolfo [1 ]
Ramos-Penafiel, Christian [1 ]
Castellanos-Sinco, Humberto [1 ]
Zamora, Jorge [1 ]
Collazo-Jaloma, Juan [1 ]
Gutierrez, Mario [1 ]
Gutierrez-Kobeh, Laila [2 ]
Chavez-Olmos, Pedro [3 ]
Manzanilla, Hugo [4 ]
Garrido-Guerrero, Efrain [3 ]
Ordonez-Razo, Rosa M. [5 ]
Miranda, Enrique I. [1 ,6 ]
机构：
[1] Hosp Gen Mexico City, Serv Hematol, Lab Biol Mol, Mexico City 06726, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Sch Med, Mexico City, DF, Mexico
[3] CINVESTAV IPN, Dept Genet & Biol Mol, Mexico City, DF, Mexico
[4] Hosp Gen Mexico City, Serv Urol, Mexico City 06726, DF, Mexico
[5] IMSS, Ctr Med Siglo 21, Hosp Pediat, Unidad Invest Med Genet Humana, Mexico City, DF, Mexico
[6] Westhill Univ, Sch Med, Mexico City, DF, Mexico
来源：
HEMATOLOGY | 2011年 / 16卷 / 06期
关键词：
MAGE-A3; Expression; Prognostic; DLBCL; Lymphoma; NON-HODGKINS-LYMPHOMA; TISSUE MICROARRAY; GENE-EXPRESSION; CANCER; CHEMOTHERAPY; PREDICTION; CARCINOMA; SURVIVAL; MYELOMA; ANTIGEN;
D O I：
10.1179/102453311X13085644680384
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This study evaluates the prognostic value of MAGE-A3 expression in 28 diffuse large B-cell lymphoma (DLBCL) patients. A significant association was observed between MAGE-A3 expressions, assessed by quantitative real-time RT-polymerase chain reaction (PCR), with advanced stages of disease (P<0.05). Elevated serum lactate dehydrogenase (LDH) levels and International Prognostic Index (IPI) score were significantly higher in MAGE-A3-positive patients (P=0.025 and P=0.004, respectively). Expression of MAGE-A3 was associated with poor response to treatment and a significantly shorter overall survival (P<0.001). Our data address new information in the association of MAGE-A3 expression and poor prognosis in DLBCL patients.
引用
收藏
页码：368 / 372
页数：5
相关论文
共 50 条
  • [1] CD43 Expression Is an Adverse Prognostic Factor in Diffuse Large B-Cell Lymphoma
    Mitrovic, Zdravko
    Ilic, Ivana
    Nola, Marin
    Aurer, Igor
    Sonicki, Zdenko
    Basic-Kinda, Sandra
    Radman, Ivo
    Ajdukovic, Radmila
    Labar, Boris
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (02) : 133 - 137
  • [2] Loss of RUNX3 expression is an independent adverse prognostic factor in diffuse large B-cell lymphoma
    Duncan, Virginia E.
    Ping, Zheng
    Varambally, Sooryanarayana
    Peker, Deniz
    LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 179 - 184
  • [3] Adverse prognostic impact of vascular endothelial growth factor gene polymorphisms in patients with diffuse large B-cell lymphoma
    Yoon, Kyong-Ah
    Kim, Min Kyeong
    Eom, Hyeon-Seok
    Lee, Hyewon
    Park, Weon Seo
    Sohn, Ji Yeon
    Kim, Man Jin
    Kong, Sun-Young
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2677 - 2682
  • [4] Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP
    Gupta, Mamta
    Maurer, Matthew J.
    Wellik, Linda E.
    Law, Mark E.
    Han, Jing Jing
    Ozsan, Nazan
    Micallef, Ivana N.
    Dogan, Ahmet
    Witzig, Thomas E.
    BLOOD, 2012, 120 (22) : 4400 - 4406
  • [5] Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
    Park, Jeayeon
    Chung, Sung Won
    Lee, Yun Bin
    Shin, Hyunjae
    Hur, Moon Haeng
    Cho, Heejin
    Park, Min Kyung
    Youk, Jeonghwan
    Lee, Ji Yun
    Lee, Jeong-Ok
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Kim, Tae Min
    Lee, Jeong-Hoon
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (03) : 794 - 809
  • [6] Diffuse large B-cell lymphoma
    Fuchs, David
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (01) : 7 - 11
  • [7] Prognostic significance of immunohistochemical classification of diffuse large B-cell lymphoma
    Alacacioglu, Inci
    Ozcan, Mehmet Ali
    Ozkal, Sermin
    Piskin, Ozden
    Turgut, Nurhilal
    Demirkan, Fatih
    Ozsan, Guner Hayri
    Kargi, Aydanur
    Undar, Bulent
    HEMATOLOGY, 2009, 14 (02) : 84 - 89
  • [8] The Enhanced International Prognostic Index for Diffuse Large B-cell Lymphoma
    Yang, Yan
    Wang, Lanlan
    Ma, Yanna
    Han, Tingting
    Huang, Mei
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 353 (05) : 459 - 465
  • [9] Prognostic factors for primary diffuse large B-cell lymphoma of the brain
    Zhou, Zhuoya
    Chen, Jing
    ASIAN JOURNAL OF SURGERY, 2023, 46 (10) : 4357 - 4362
  • [10] The Prognostic Importance of Immunohistochemical Biomarkers in Diffuse Large B-Cell Lymphoma
    Korkmaz, S.
    Sencan, M.
    Yildiz, E.
    Terzi, H.
    Egilmez, R.
    WEST INDIAN MEDICAL JOURNAL, 2021, 69 (01) : 38 - 43
12345